Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Prostate cancer in Denmark. Incidence, morbidity and mortality

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Carcinoma of the prostate. Classification

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Carcinoma of the prostate. Early diagnosis--screening

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Carcinoma of the prostate. Prognostic factors

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Novel functions of the luteinizing hormone/chorionic gonadotropin receptor in prostate cancer cells and patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. AZGP1 Protein Expression in Hormone-Naïve Advanced Prostate Cancer Treated with Primary Androgen Deprivation Therapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Prostate cancer incidence and mortality rates in Denmark are reviewed for a 50-year period from 1943 to 1992. The prostate cancer incidence rate nearly tripled and prostate cancer mortality rate increased during this period. Until recently in Denmark the routine management of prostate cancer has been by deferred hormonal therapy. Morbidity and mortality associated with prostate cancer are analysed in a group of 1459 patients aged 55-74 years, who were diagnosed as having clinically localized prostate cancer in the 5-year period 1983 to 1987. In this group of patients prostate cancer is demonstrated to cause significant morbidity. Furthermore, the patients suffered significant excess mortality and loss of life expectancy.
Original languageEnglish
Book seriesScandinavian Journal of Urology and Nephrology. Supplement
Volume203
Pages (from-to)29-33
Number of pages5
ISSN0300-8886
Publication statusPublished - 1999

    Research areas

  • Aged, Denmark, Humans, Incidence, Male, Middle Aged, Prostatic Neoplasms

ID: 36730531